NEXGEL, Inc. (NXGLW)

0.4370 0.0000 (0.00%) At close: 04:00PM EDT

NEXGEL, Inc.

2150 Cabot Boulevard West
Suite B
Langhorne, PA 19047
United States
215 702 8550
https://nexgel.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 19

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Adam R. Levy	CEO, President & Director	382.2k	N/A	1963
Mr. Adam E. Drapczuk III	Chief Financial Officer	208.68k	N/A	1977
Mr. Gregory Robb	Vice President of Operations	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Corporate Governance

NEXGEL, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.